Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Retained Earnings (2022 - 2025)

Historic Retained Earnings for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$429.3 million.

  • InflaRx's Retained Earnings fell 1950.18% to -$429.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$429.3 million, marking a year-over-year decrease of 1950.18%. This contributed to the annual value of -$359.5 million for FY2024, which is 1678.96% down from last year.
  • Per InflaRx's latest filing, its Retained Earnings stood at -$429.3 million for Q3 2025, which was down 1950.18% from -$401.8 million recorded in Q2 2025.
  • InflaRx's Retained Earnings' 5-year high stood at -$237.4 million during Q3 2022, with a 5-year trough of -$429.3 million in Q3 2025.
  • In the last 4 years, InflaRx's Retained Earnings had a median value of -$307.9 million in 2023 and averaged -$313.6 million.
  • The largest annual percentage gain for InflaRx's Retained Earnings in the last 5 years was 677.88% (2023), contrasted with its biggest fall of 2394.09% (2023).
  • Quarter analysis of 4 years shows InflaRx's Retained Earnings stood at -$248.4 million in 2022, then dropped by 23.94% to -$307.9 million in 2023, then fell by 15.31% to -$355.0 million in 2024, then fell by 20.92% to -$429.3 million in 2025.
  • Its last three reported values are -$429.3 million in Q3 2025, -$401.8 million for Q2 2025, and -$358.2 million during Q1 2025.